Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Clinical trial NCT00003461 · COMPLETED

Trial details

NCT number: NCT00003461
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Metastatic Cancer Neuroblastoma

Start date: 1998-02-01
Primary completion: 2005-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.